Come up with a name for your new list and we'll add to it:
Perthera raised a round of funding on June 28, 2016. Investors include
Pilot Growth Equity.
Personalized Cancer Therapy, dba Perthera, is the market and technology leader in developing Precision Cancer Analysis ("PCA") used to provide detailed molecular information about cancer tumors. The …